Picture EBD Group World of Partnering Opportunities 650x100px

Product › Details

ImO1100 (Rigontec)

	Next higher product group	mRNA-based drug
	Status	2014-10-14 development pp existent
	Organisation	Rigontec GmbH
	Group	Merck (US) (MSD) (Group)
	Original research	University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn)

Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for mRNA-based drug

[1] Pantherna Therapeutics GmbH / Wacker. (4/5/24). "Press Release: Pantherna and Wacker Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals". Munich & Hennigsdorf....
[2] BioNTech AG. (3/1/23). "Press Release: BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel". Jerusalem....
[3] CureVac N.V.. (2/8/23). "Press Release: CureVac Announces Pricing of Upsized Public Offering of Common Shares". Tübingen & Boston, MA....
[4] CureVac N.V.. (2/6/23). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA....
[5] BioNTech SE. (2/2/23). "Press Release: BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility". Mainz....
[6] BioNTech SE. (11/14/22). "Press Release: BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore". Mainz & Singapore....
[7] BeiGene, Ltd.. (7/6/22). "Press Release: BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies". Cambridge, MA, Basel & Beijing....
[8] Pantherna Therapeutics GmbH. (1/11/22). "Press Release: Pantherna Therapeutics Secures EUR 4.0 Mio. Follow-on Financing to Advance Its Therapeutic mRNA Development Programs". Hennigsdorf....
[9] CureVac N.V.. (9/14/21). "Press Release: CureVac Streamlines European Network for mRNA Product Manufacturing". Tübingen & Boston, MA....
[10] CureVac N.V.. (8/30/21). "Press Release: CureVac Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRNA Therapeutic". Tübingen & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)